These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 27287888)
1. Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome. Brehmer B; Kauffmann C; Blank C; Heidenreich A; Bex A World J Urol; 2016 Aug; 34(8):1061-6. PubMed ID: 27287888 [TBL] [Abstract][Full Text] [Related]
3. The Significance of Metastasectomy in Patients with Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy. Yu X; Wang B; Li X; Lin G; Zhang C; Yang Y; Fang D; Song Y; He Z; Zhou L Biomed Res Int; 2015; 2015():176373. PubMed ID: 26568955 [TBL] [Abstract][Full Text] [Related]
4. Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: an 18 years of experience. Renaud S; Falcoz PE; Alifano M; Olland A; Magdeleinat P; Pagès O; Regnard JF; Massard G J Surg Oncol; 2014 Jun; 109(8):823-9. PubMed ID: 24619772 [TBL] [Abstract][Full Text] [Related]
5. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma. Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360 [TBL] [Abstract][Full Text] [Related]
6. Surgery for renal cell carcinoma metastases. Breau RH; Blute ML Curr Opin Urol; 2010 Sep; 20(5):375-81. PubMed ID: 20592612 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Hofmann HS; Neef H; Krohe K; Andreev P; Silber RE Eur Urol; 2005 Jul; 48(1):77-81; discussion 81-2. PubMed ID: 15967255 [TBL] [Abstract][Full Text] [Related]
9. Twelve-year survival after multiple recurrences and repeated metastasectomies for renal cell carcinoma. Wang J; Talmon GA; Feloney M; Morris MC World J Surg Oncol; 2011 Nov; 9():155. PubMed ID: 22123271 [TBL] [Abstract][Full Text] [Related]
10. Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era. Takagi T; Fukuda H; Ishihara H; Yoshida K; Kondo T; Kobayashi H; Iizuka J; Okumi M; Ishida H; Omae K; Tanabe K Urol Oncol; 2020 May; 38(5):515-520. PubMed ID: 32146128 [TBL] [Abstract][Full Text] [Related]
11. Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma. You D; Lee C; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Ahn H; Kim CS J Cancer Res Clin Oncol; 2016 Nov; 142(11):2331-8. PubMed ID: 27553579 [TBL] [Abstract][Full Text] [Related]
12. Complete Surgical Metastasectomy of Renal Cell Carcinoma in the Post-Cytokine Era. Lyon TD; Thompson RH; Shah PH; Lohse CM; Boorjian SA; Costello BA; Cheville JC; Leibovich BC J Urol; 2020 Feb; 203(2):275-282. PubMed ID: 31393812 [TBL] [Abstract][Full Text] [Related]
13. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors. Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645 [TBL] [Abstract][Full Text] [Related]